Ingebrigtsen TS - Search Results

1

[Physicians should increase focus on poor medicine adherence among chronically ill patients].

Tøttenborg SS, Topp M, Ingebrigtsen TS, Lange P. Tøttenborg SS, et al. Among authors: ingebrigtsen ts. Ugeskr Laeger. 2014 Oct 13;176(42):V05130287. Ugeskr Laeger. 2014. PMID: 25316358 Free article. Review. Danish.

2

Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.

Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG. Lange P, et al. Among authors: ingebrigtsen ts. Am J Respir Crit Care Med. 2012 Nov 15;186(10):975-81. doi: 10.1164/rccm.201207-1299OC. Epub 2012 Sep 20. Am J Respir Crit Care Med. 2012. PMID: 22997207

3

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Thomsen M, et al. Among authors: ingebrigtsen ts. JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732. JAMA. 2013. PMID: 23757083

4

Characteristics of undertreatment in COPD in the general population.

Ingebrigtsen TS, Marott JL, Vestbo J, Hallas J, Nordestgaard BG, Dahl M, Lange P. Ingebrigtsen TS, et al. Chest. 2013 Dec;144(6):1811-1818. doi: 10.1378/chest.13-0453. Chest. 2013. PMID: 23989916

5

Socioeconomic status and prognosis of COPD in Denmark.

Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG. Lange P, et al. Among authors: ingebrigtsen ts. COPD. 2014 Aug;11(4):431-7. doi: 10.3109/15412555.2013.869580. Epub 2014 Feb 25. COPD. 2014. PMID: 24568315

6

Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.

Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Dahl M, Vestbo J. Ingebrigtsen TS, et al. J Gen Intern Med. 2015 Jan;30(1):51-9. doi: 10.1007/s11606-014-3029-0. Epub 2014 Sep 23. J Gen Intern Med. 2015. PMID: 25245885 Free PMC article.

7

Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease.

Ingebrigtsen TS, Marott JL, Vestbo J, Nordestgaard BG, Hallas J, Lange P. Ingebrigtsen TS, et al. Respirology. 2015 Jan;20(1):101-7. doi: 10.1111/resp.12420. Epub 2014 Oct 8. Respirology. 2015. PMID: 25297724

8

Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.

Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J. Ingebrigtsen TS, et al. Thorax. 2015 Jan;70(1):33-40. doi: 10.1136/thoraxjnl-2014-205795. Epub 2014 Oct 27. Thorax. 2015. PMID: 25349333 Clinical Trial.

9

Fibrinogen and α1-antitrypsin in COPD exacerbations.

Ingebrigtsen TS, Marott JL, Rode L, Vestbo J, Lange P, Nordestgaard BG. Ingebrigtsen TS, et al. Thorax. 2015 Nov;70(11):1014-21. doi: 10.1136/thoraxjnl-2015-207561. Epub 2015 Aug 24. Thorax. 2015. PMID: 26304913

10

Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.

Ingebrigtsen TS, Marott JL, Lange P, Hallas J, Nordestgaard BG, Vestbo J. Ingebrigtsen TS, et al. Respir Med. 2015 Dec;109(12):1562-8. doi: 10.1016/j.rmed.2015.10.015. Epub 2015 Oct 31. Respir Med. 2015. PMID: 26560643 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page